Focused On Globalization, Shanghai FDA Will Hold International Forum On Drug Safety And Regulatory Change
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In an effort to fast-forward the globalization of China's drug laws and utlimately boost its exports of pharmaceuticals, the Shanghai FDA is partnering with a U.S.-based law firm to co-host its first international forum on drug safety and regulatory change
You may also be interested in...
China’s Supreme Court States Doctors Accepting Bribes Can Be Criminally Prosecuted
BEIJING - China's Supreme People's Court has issued a legal document that will make it easier and more likely for doctors accepting bribes to be prosecuted under the country's criminal law
China’s Supreme Court States Doctors Accepting Bribes Can Be Criminally Prosecuted
BEIJING - China's Supreme People's Court has issued a legal document that will make it easier and more likely for doctors accepting bribes to be prosecuted under the country's criminal law
China Eager To Establish Pharmacovigilance System – SFDA Officials
SHANGHAI - In an effort to ensure drug safety, China will establish a pharmacovigilance system and will continue to improve its adverse drug reaction reports system, said Yan Ming, director of the drug re-evaluation division under China's State FDA drug safety and inspection department, during an international conference on post-market drug safety Oct. 29 in Shanghai